Special Considerations for Primary and Secondary Stroke Prevention in Women

Abstract

There are gender differences in stroke in several areas. Overall, the incidence of stroke is greater in women because of the increased risk of stroke with increasing age and the longer life expectancy of women. However, gender-specific risk factors for stroke include hormonal changes during pregnancy and exogenous hormonal therapies. Also, cerebral venous thrombosis, thrombophilia, and migraine are more prevalent in women. These gender differences are the subject of this review.

Keywords

stroke - women - prevention - pregnancy - gender

• References

• 1 Moatti Z, Gupta M, Yadava R, Thamban S. A review of stroke and pregnancy: incidence, management and prevention. Eur J Obstet Gynecol Reprod Biol 2014; 181: 20-27
• 2 Bushnell C, McCullough L, Awad I. , et al. Guidelines for the Prevention of Stroke in Women. Stroke. 2014 . Available at: https://doi.org/10.1161/01.str.0000442009.06663.48 . Accessed September 26, 2016
• 3 Tettenborn B. Stroke and pregnancy. Neurol Clin 2012; 30 (03) 913-924
• 4 Roberts JM, August PA, Bakris G. , et al; American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
• 5 Xu TT, Zhou F, Deng CY, Huang GQ, Li JK, Wang XD. Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis. J Clin Hypertens (Greenwich) 2015; 17 (07) 567-573
• 6 Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; (02) CD002252
• 7 Magee LA, von Dadelszen P, Rey E. , et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015; 372 (05) 407-417
• 8 Magee LA, Helewa M, Moutquin JM, von Dadelszen P. ; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30 (3, Suppl): S1-S48
• 9 ElFarra J, Bean C, Martin Jr JN. Management of hypertensive crisis for the obstetrician/gynecologist. Obstet Gynecol Clin North Am 2016; 43 (04) 623-637
• 10 Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010; (11) CD000025
• 11 Sass N, Itamoto CH, Silva MP, Torloni MR, Atallah AN. Does sodium nitroprusside kill babies? A systematic review. Sao Paulo Med J 2007; 125 (02) 108-111
• 12 Ghanem FA, Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther 2008; 26 (01) 38-49
• 13 American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care 2016; 39 (Suppl. 01) S94-S98
• 14 Mukherjee M. Dyslipidemia in pregnancy. Expert analysis, America College of Cardiology. 2014 . Available at: http://www.acc.org/latest-in-cardiology/articles/2014/07/18/16/08/dyslipidemia-in-pregnancy . Accessed November 28, 2016
• 15 Kelly JC, Safain MG, Roguski M, Edlow AG, Malek AM. Postpartum internal carotid and vertebral arterial dissections. Obstet Gynecol 2014; 123 (04) 848-856
• 16 Reinhard M, Munz M, von Kannen AL, Griesser-Leute HJ, Dittrich R, Engelter ST. Risk of recurrent cervical artery dissection during pregnancy, childbirth and puerperium. Eur J Neurol 2015; 22 (04) 736-739
• 17 Moroz L, Airoldi J, Almario C, Greenberg M, Berghella V, Baxter J. Prophylactic treatment during pregnancy for women with a history of vertebral artery dissection. Am J Obstet Gynecol 2006; 195 (06) S104
• 18 Abecassis P, Lecinq A, Roger-Christoph S, Mercier FJ, Benhamou D. [Management of delivery in patients with Marfan's syndrome presenting aortic dilatation]. J Gynecol Obstet Biol Reprod (Paris) 2004; 33 (05) 416-420
• 19 Lamy C, Hamon JB, Coste J, Mas JL. ; French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology 2000; 55 (02) 269-274
• 20 Putaala J, Haapaniemi E, Metso AJ. , et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol 2010; 68 (05) 661-671
• 21 Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. ; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e691S-e736S
• 22 Gupta U, Cook JC, Tassinari MS, Hurtt ME. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms. Birth Defects Res B Dev Reprod Toxicol 2003; 68 (01) 27-37
• 23 Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002; 187 (06) 1623-1630
• 24 Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. ; PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369 (9575): 1791-1798
• 25 Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130 (10) 800-809
• 26 Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140 (03) 175-183
• 27 Kaplan LC. Congenital Dandy Walker malformation associated with first trimester warfarin: a case report and literature review. Teratology 1985; 32 (03) 333-337
• 28 Xu Z, Li Y, Tang S, Huang X, Chen T. Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies. Thromb Res 2015; 136 (01) 52-60
• 29 Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000; 284 (01) 72-78
• 30 Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366 (24) 2257-2266
• 31 Kemmeren JM, Tanis BC, van den Bosch MA. , et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33 (05) 1202-1208
• 32 Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8 (11) 998-1005
• 33 Piepoli MF, Hoes AW, Agewall S. , et al; Authors/Task Force Members. 2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2016; 37 (29) 2315-2381
• 34 Curtis KM, Tepper NK, Jatlaoui TC. , et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65 (3, No. RR-3): 1-103
• 35 Black A, Guilbert E, Costescu D. , et al; Co-Authors; Special Contributors. Canadian Contraception Consensus (Part 2 of 4). J Obstet Gynaecol Can 2015; 37 (11) 1033-1039
• 36 Lisabeth L, Bushnell C. Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol 2012; 11 (01) 82-91
• 37 Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown Jr RD. Premature menopause or early menopause and risk of ischemic stroke. Menopause 2012; 19 (03) 272-277
• 38 Grady D, Herrington D, Bittner V. , et al; HERS Research Group. Cardiovascular Disease Outcomes during 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II). JAMA 2002; 288 (01) 49-57
• 39 Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke. N Engl J Med 2001; 345 (17) 1243-1249
• 40 Rossouw JE, Anderson GL, Prentice RL. , et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288 (03) 321-333
• 41 Canonico M, Carcaillon L, Plu-Bureau G. , et al. Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen. Stroke 2016; 47 (07) 1734-1741
• 42 de Villiers TJ, Hall JE, Pinkerton JV. , et al. Revised global consensus statement on menopausal hormone therapy. Maturitas 2016; 91: 153-155
• 43 Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE. ; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause. Endocr Pract 2011; 17 (06) (Suppl. 06) 1-25
• 44 Reid R, Abramson BL, Blake J. , et al; Menopause and Osteoporosis Working Group. Managing menopause. J Obstet Gynaecol Can 2014; 36 (09) 830-833
• 45 Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123 (07) 612-624
• 46 Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: b3914
• 47 MacClellan LR, Giles W, Cole J. , et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007; 38 (09) 2438-2445
• 48 Hicks T, Stewart F, Eisinga A. NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis. Open Heart 2016; 3 (01) e000279
• 49 Connolly SJ, Ezekowitz MD, Yusuf S. , et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361 (12) 1139-1151
• 50 Granger CB, Alexander JH, McMurray JJ. , et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365 (11) 981-992
• 51 Pancholy SB, Sharma PS, Pancholy DS, Patel TM, Callans DJ, Marchlinski FE. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol 2014; 113 (03) 485-490
• 52 Alamowitch S, Eliasziw M, Barnett HJ. ; North American Symptomatic Carotid Endarterectomy Trial (NASCET); ASA Trial Group; Carotid Endarterectomy (ACE) Trial Group. The risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease. Stroke 2005; 36 (01) 27-31
• 53 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363 (9413): 915-924
• 54 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35 (12) 2855-2861
• 55 Howard VJ, Lutsep HL, Mackey A. , et al; CREST investigators. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol 2011; 10 (06) 530-537
• 56 De Rango P, Brown MM, Leys D. , et al. Management of carotid stenosis in women: consensus document. Neurology 2013; 80 (24) 2258-2268